• intent@hq.icmr.org.in

Existing gaps

  • India with 18% of the global population conducts only 1·4% of global clinical trials.
  • Regulatory clinical trial capacity traditionally exist with pharmaceutical industry and CROs.
  • Individuals are frequently sceptic to participate.
  • Academic centres lack critical capacity in areas such as regulatory compliance, data management, etc. and restrict themselves to Non-regulatory trials.

Phase-II/III Trial Centers

Zoomable Image

# Institute Details
55 JIPMER Puducherry
56 St. John’s Medical College, Bengaluru
57 Amrita Institute of Medical Sciences, Kochi
58 LV Prasad Eye Institute, Hyderabad
59 Sri Ramachandra Institute of Higher Education, Chennai
60 CChristian Medical College, Vellore, Tamil Nadu
61 Yenepoya Medical College Hospital, Yenepoya (Deemed to be University) City, Mangalore, Karnataka
62 ICMR-National Institute of Traditional Medicine, Belagavi, Karnataka
63 JSS Academy of Higher Education and Research, Mysuru, Karnataka
64 Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, Karnataka
65 Chettinad Hospital and Research Institute, Chettinad Academy of Research and Education,Chengalpattu, Chennai, Tamilnadu
66 Gandhi Medical College, Secunderabad, Telangana
67 Tirunelveli Medical College, Tirunelveli, Tamil Nadu
68 Karnataka Institute of Medical Sciences, Hubli, Karnataka Delhi
69 Pondicherry Institute of Medical Sciences, Puducherry
70 DM Wayanad Medical College, Waynad, Kerala
71 Narayana Medical College & Hospital, Nellore
72 Jawaharlal Nehru Medical College, KLE Academy of Higher Education and Research Belagavi, Karnataka
73 SRM Medical College Hospital & Research Centre, Chennai, Tamil Nadu
74 National Institute for Research in Tuberculosis (NIRT), Chennai, Tamil Nadu
75 National Institute of Mental Health and Neurosciences (NIMHANS), Bengaluru, Karnataka
76 Sree Chitra Tirunal Institute for Medical Sciences & Technology, Trivandrum
77 The George Institute of Public Health, Hyderabad, Telangana
78 Indira Gandhi Institute of Child Health, Bangalore, Karnataka
79 SAT Hospital, Government Medical College, Thiruvananthapuram, Kerala
80 Nizam's Institute of Medical Sciences, Hyderabad, Telangana
81 Institute of Child Health And Hospital for Children, Egmore, Chennai, Tamilnadu

Expected outcomes

  • Build capacity of investigators through training and collaboration.
  • Improve capability to conduct academic as well as regulatory clinical trials.
  • Improve the clinical trial ecosystem by trial methodology research, frequent interaction with stakeholders, regulatory research etc.
  • Improve representation of the diverse Indian community.
  • Instil confidence in Indian study participants through transparency and advocacy.
  • Identify and support a plug-and-play clinical trial network that can readily evaluate health products that are of national health priority.
  • Conduct large decisive trials, in areas of National Health Priorities.
  • Clinical development of indigenous drugs, vaccines, devices and diagnostics.
  • Provide evidence-based, cost effective, scientifically sound and culturally sensitive solutions to problems.
  • Influence health policies and practices.